Advertisement

Influence of Wear Particles on Local and Systemic Immune System

  • Emmanuel GibonEmail author
  • Stuart B. Goodman
Chapter

Abstract

Decreasing periprosthetic osteolysis due to wear particles is a current challenge and an on-going research endeavor to prolong the longevity of joint replacements. The aim of this chapter is to provide the reader keys to the understanding of how the immune system interacts with metallic and non metallic wear particles and other byproducts from joint replacements. The local and systemic immune system is involved in a complex network of chemokines, cytokines, and different cell types which in the end leads to inflammation and a foreign body reaction.

Keywords

Wear debris Immune reactions Cytokines Cells 

References

  1. 1.
    Bozic KJ, Kurtz S, Lau E, et al. The epidemiology of bearing surface usage in total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91:1614–20.PubMedCrossRefGoogle Scholar
  2. 2.
    Bozic KJ, Ong K, Lau E, et al. Risk of complication and revision total hip arthroplasty among Medicare patients with different bearing surfaces. Clin Orthop Relat Res. 2010;468:2357–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Sundfeldt M, Carlsson LV, Johansson CB, et al. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop. 2006;77:177–97.PubMedCrossRefGoogle Scholar
  4. 4.
    Bozic KJ, Kurtz SM, Lau E, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2009;468:45–51.PubMedCrossRefGoogle Scholar
  5. 5.
    Ries MD, Scott ML, Jani S. Relationship between gravimetric wear and particle generation in hip simulators: conventional compared with cross-linked polyethylene. J Bone Joint Surg Am. 2001;83-A(Suppl 2 Pt 2):116–22.PubMedGoogle Scholar
  6. 6.
    Campbell P, Ma S, Yeom B, et al. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues. J Biomed Mater Res. 1995;29:127–31.PubMedCrossRefGoogle Scholar
  7. 7.
    Doorn PF, Campbell PA, Worrall J, et al. Metal wear particle characterization from metal on metal total hip replacements: transmission electron microscopy study of periprosthetic tissues and isolated particles. J Biomed Mater Res. 1998;42:103–11.PubMedCrossRefGoogle Scholar
  8. 8.
    Ingham E, Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials. 2005;26:1271–86.PubMedCrossRefGoogle Scholar
  9. 9.
    Hatton A, Nevelos JE, Nevelos AA, et al. Alumina-alumina artificial hip joints. Part I: a histological analysis and characterisation of wear debris by laser capture microdissection of tissues retrieved at revision. Biomaterials. 2002;23:3429–40.PubMedCrossRefGoogle Scholar
  10. 10.
    Goodman SB. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials. 2007;28:5044–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Schmalzried TP, Jasty M, Harris WH. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am. 1992;74:849–63.PubMedGoogle Scholar
  12. 12.
    Xing S, Waddell JE, Boynton EL. Changes in macrophage morphology and prolonged cell viability following exposure to polyethylene particulate in vitro. Microsc Res Tech. 2002;57:523–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Tuan RS, Lee FY, T Konttinen Y, et al. What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles? J Am Acad Orthop Surg. 2008;16 Suppl 1:S42–8.PubMedGoogle Scholar
  14. 14.
    Pearl JI, Ma T, Irani AR, et al. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials. 2011;32:5535–42.PubMedCrossRefGoogle Scholar
  15. 15.
    Willert HG, Semlitsch M. Reactions of the articular capsule to wear products of artificial joint prostheses. J Biomed Mater Res. 1977;11:157–64.PubMedCrossRefGoogle Scholar
  16. 16.
    Goodman SB, Lind M, Song Y, Smith RL. In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop Relat Res. 1998;352:25–34.Google Scholar
  17. 17.
    Santavirta S, Konttinen YT, Bergroth V, et al. Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J Bone Joint Surg Am. 1990;72:252–8.PubMedGoogle Scholar
  18. 18.
    Rakshit DS, Ly K, Sengupta TK, et al. Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis. J Bone Joint Surg Am. 2006;88:788–99.PubMedCrossRefGoogle Scholar
  19. 19.
    Goodman SB, Huie P, Song Y, et al. Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Br. 1998;80:531–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Green TR, Fisher J, Matthews JB, et al. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res. 2000;53:490–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Goodman SB, Trindade M, Ma T, et al. Pharmacologic modulation of periprosthetic osteolysis. Clin Orthop Relat Res. 2005;430:39–45.Google Scholar
  22. 22.
    Cook DN. The role of MIP-1 alpha in inflammation and hematopoiesis. J Leukoc Biol. 1996;59:61–6.PubMedGoogle Scholar
  23. 23.
    Horowitz SM, Gonzales JB. Effects of polyethylene on macrophages. J Orthop Res. 1997;15:50–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Archibeck MJ, Jacobs JJ, Roebuck KA, Glant TT. The basic science of periprosthetic osteolysis. Instr Course Lect. 2001;50:185–95.PubMedGoogle Scholar
  25. 25.
    Moilanen E, Moilanen T, Knowles R, et al. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol. 1997;150:881–7.PubMedGoogle Scholar
  26. 26.
    Wang ML, Hauschka PV, Tuan RS, Steinbeck MJ. Exposure to particles stimulates superoxide production by human THP-1 macrophages and avian HD-11EM osteoclasts activated by tumor necrosis factor-alpha and PMA. J Arthroplasty. 2002;17:335–46.PubMedCrossRefGoogle Scholar
  27. 27.
    Shanbhag AS, Macaulay W, Stefanovic-Racic M, Rubash HE. Nitric oxide release by macrophages in response to particulate wear debris. J Biomed Mater Res. 1998;41:497–503.PubMedCrossRefGoogle Scholar
  28. 28.
    Horiki M, Nakase T, Myoui A, et al. Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab. 2004;22:346–51.PubMedCrossRefGoogle Scholar
  29. 29.
    Wang C-T, Lin Y-T, Chiang B-L, et al. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials. 2010;31:77–82.PubMedCrossRefGoogle Scholar
  30. 30.
    Stern PH, Krieger NS, Nissenson RA, et al. Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest. 1985;76:2016–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Takahashi N, MacDonald BR, Hon J, et al. Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest. 1986;78:894–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Clohisy JC, Frazier E, Hirayama T, Abu-Amer Y. RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J Orthop Res. 2003;21:202–12.PubMedCrossRefGoogle Scholar
  33. 33.
    Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992;307:97–101.PubMedCrossRefGoogle Scholar
  34. 34.
    Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther. 2003;5:32–45.PubMedCrossRefGoogle Scholar
  35. 35.
    Chen FH, Rousche KT, Tuan RS. Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol. 2006;2:373–82.PubMedCrossRefGoogle Scholar
  36. 36.
    Huang Z, Ma T, Ren P-G, et al. Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells. J Biomed Mater Res A. 2010;94:1264–9.PubMedGoogle Scholar
  37. 37.
    Goldring SR, Jasty M, Roelke MS, et al. Formation of a synovial-like membrane at the bone-cement interface. Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum. 1986;29:836–42.PubMedCrossRefGoogle Scholar
  38. 38.
    Goodman SB, Chin RC, Chiou SS, et al. A clinical-pathologic-biochemical study of the membrane surrounding loosened and nonloosened total hip arthroplasties. Clin Orthop Relat Res. 1989;244:182–7.Google Scholar
  39. 39.
    Elliott MJ, Vadas MA, Cleland LG, et al. IL-3 and granulocyte-macrophage colony-stimulating factor stimulate two distinct phases of adhesion in human monocytes. J Immunol (Baltimore, Md: 1950). 1990;145:167–76.Google Scholar
  40. 40.
    McInnes A, Rennick DM. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J Exp Med. 1988;167:598–611.PubMedCrossRefGoogle Scholar
  41. 41.
    McNally AK, Anderson JM. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol. 1995;147:1487–99.PubMedGoogle Scholar
  42. 42.
    al-Saffar N, Mah JT, Kadoya Y, Revell PA. Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants. Ann Rheum Dis. 1995;54:201–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Firkins PJ, Tipper JL, Saadatzadeh MR, et al. Quantitative analysis of wear and wear debris from metal-on-metal hip prostheses tested in a physiological hip joint simulator. Biomed Mater Eng. 2001;11:143–57.PubMedGoogle Scholar
  44. 44.
    Willert H-G, Buchhorn GH, Fayyazi A, et al. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am. 2005;87:28–36.PubMedCrossRefGoogle Scholar
  45. 45.
    Park Y-S, Moon Y-W, Lim S-J, et al. Early osteolysis following second-generation metal-on-metal hip replacement. J Bone Joint Surg Am. 2005;87:1515–21.PubMedCrossRefGoogle Scholar
  46. 46.
    Davies AP, Willert HG, Campbell PA, et al. An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg Am. 2005;87:18–27.PubMedCrossRefGoogle Scholar
  47. 47.
    Witzleb W-C, Hanisch U, Kolar N, et al. Neo-capsule tissue reactions in metal-on-metal hip arthroplasty. Acta Orthop. 2007;78:211–20.PubMedCrossRefGoogle Scholar
  48. 48.
    Hallab NJ, Anderson S, Stafford T, et al. Lymphocyte responses in patients with total hip arthroplasty. J Orthop Res. 2005;23:384–91.PubMedCrossRefGoogle Scholar
  49. 49.
    Lalor PA, Revell PA. T-lymphocytes and titanium aluminium vanadium (TiAlV) alloy: evidence for immunological events associated with debris deposition. Clin Mater. 1993;12:57–62.CrossRefGoogle Scholar
  50. 50.
    Bainbridge JA, Revell PA, Al-Saffar N. Costimulatory molecule expression following exposure to orthopaedic implants wear debris. J Biomed Mater Res. 2001;54:328–34.PubMedCrossRefGoogle Scholar
  51. 51.
    McKay GC, Macnair R, MacDonald C, Grant MH. Interactions of orthopaedic metals with an immortalized rat osteoblast cell line. Biomaterials. 1996;17:1339–44.PubMedCrossRefGoogle Scholar
  52. 52.
    Fleury C, Petit A, Mwale F, et al. Effect of cobalt and chromium ions on human MG-63 osteoblasts in vitro: morphology, cytotoxicity, and oxidative stress. Biomaterials. 2006;27:3351–60.PubMedCrossRefGoogle Scholar
  53. 53.
    Anissian L, Stark A, Dahlstrand H, et al. Cobalt ions influence proliferation and function of human osteoblast-like cells. Acta Orthop Scand. 2002;73:369–74.PubMedCrossRefGoogle Scholar
  54. 54.
    Morais S, Sousa JP, Fernandes MH, Carvalho GS. In vitro biomineralization by osteoblast-like cells. I. Retardation of tissue mineralization by metal salts. Biomaterials. 1998;19:13–21.PubMedCrossRefGoogle Scholar
  55. 55.
    Fernandes MH. Effect of stainless steel corrosion products on in vitro biomineralization. J Biomater Appl. 1999;14:113–68.PubMedGoogle Scholar
  56. 56.
    MacQuarrie RA, Fang Chen Y, Coles C, Anderson GI. Wear-particle-induced osteoclast osteolysis: the role of particulates and mechanical strain. J Biomed Mater Res B Appl Biomater. 2004;69:104–12.PubMedCrossRefGoogle Scholar
  57. 57.
    Nichols KG, Puleo DA. Effect of metal ions on the formation and function of osteoclastic cells in vitro. J Biomed Mater Res. 1997;35:265–71.PubMedCrossRefGoogle Scholar
  58. 58.
    Manlapaz M, Maloney WJ, Smith RL. In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. J Orthop Res. 1996;14:465–72.PubMedCrossRefGoogle Scholar
  59. 59.
    Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J. 1994;8:854–61.PubMedGoogle Scholar
  60. 60.
    Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med. 2002;32:1102–15.PubMedCrossRefGoogle Scholar
  61. 61.
    Wolf T, Kasemann R, Ottenwälder H. Molecular interaction of different chromium species with nucleotides and nucleic acids. Carcinogenesis. 1989;10:655–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Witkiewicz-Kucharczyk A, Bal W. Damage of zinc fingers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol Lett. 2006;162:29–42.PubMedCrossRefGoogle Scholar
  63. 63.
    Ren PG, Irani A, Huang Z, et al. Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis. Clin Orthop Relat Res. 2011;469:113–22.PubMedCrossRefGoogle Scholar
  64. 64.
    Ren PG, Lee SW, Biswal S, Goodman SB. Systemic trafficking of macrophages induced by bone cement particles in nude mice. Biomaterials. 2008;29:4760–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29:313–26.PubMedCrossRefGoogle Scholar
  66. 66.
    Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev. 2002;13:455–81.PubMedCrossRefGoogle Scholar
  67. 67.
    Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am. 2001;83-A:428–36.PubMedGoogle Scholar
  68. 68.
    Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem/FEBS. 2001;268:42–7.CrossRefGoogle Scholar
  69. 69.
    Clodfelder BJ, Emamaullee J, Hepburn DD, et al. The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. J Biol Inorg Chem. 2001;6:608–17.PubMedCrossRefGoogle Scholar
  70. 70.
    Eitinger T, Suhr J, Moore L, Smith JAC. Secondary transporters for nickel and cobalt ions: theme and variations. Biometals. 2005;18:399–405.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2012

Authors and Affiliations

  1. 1.Department of Orthopaedic SurgeryStanford University School of MedicineStanfordUSA
  2. 2.Department of Orthopaedic SurgeryBichat Teaching Hospital, Paris School of Medicine, Paris VII UniversityParisFrance
  3. 3.Department of Orthopaedic SurgeryStanford University School of MedicineRedwood CityUSA

Personalised recommendations